直接前入路与微后入路全髋关节置换术随机临床试验:7.5年时小的早期功能差异未导致有意义的临床差异
这项随机临床试验比较直接前入路(DAA)与微后入路(MPA)全髋关节置换术,101例原入组患者中93例在中位7.5年随访时 eligible。结果显示Harris髋关节评分、12项简表健康调查及髋关节残疾与骨关节炎结局评分(HOOS)均相似,无临床结局达到最小临床重要差异,两组并发症、再手术和翻修无临床意义差异。
要点
- 中位7.5年随访时,DAA与MPA组Harris髋关节评分相似(95.3±6.0 vs 93.5±10.3,P=.79)。
- HOOS生活质量亚评分DAA组96.9±10.8 vs MPA组92.3±16.0(P=.046),但无临床结局达到最小临床重要差异。
- 两组并发症、再手术和翻修无临床意义差异。
核心结论
- 在中位7.5年时,该随机临床试验表明DAA与MPA全髋关节置换术在结局、并发症、再手术或翻修方面无临床意义差异。
研究设计与样本
- 随机临床试验,原入组101例患者,93例在中位7.5年(范围2.1至10年)时符合随访条件。
主要发现
- Harris髋关节评分DAA组95.3±6.0 vs MPA组93.5±10.3(P=.79)。
- 12项简表健康调查躯体评分DAA组46.2±9.3 vs MPA组46.2±10.6(P=.79),心理评分DAA组52.3±7.1 vs MPA组55.2±4.5(P=.07)。
- HOOS评分DAA组97.4±7.9 vs MPA组96.3±6.7(P=.07);HOOS生活质量亚评分DAA组96.9±10.8 vs MPA组92.3±16.0(P=.046)。
- 无临床结局达到最小临床重要差异。
- DAA组4例手术并发症(1例股骨松动需翻修、1例脱位闭合复位、2例伤口裂开需清创);MPA组6例手术并发症(3例脱位,2例闭合复位、1例翻修为双动头;2例术中骨折钢缆固定;1例伤口裂开非手术治疗)。
局限性
- 证据等级为IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our previously reported randomized clinical trial of direct anterior approach (DAA) versus mini-posterior approach (MPA) total hip arthroplasty showed slightly faster initial recovery for patients who had a DAA and no differences in complications or clinical or radiographic outcomes beyond 8 weeks. The aims of the current study were to determine if early advantages of DAA led to meaningful clinical differences beyond 5 years and to identify differences in midterm complications. METHODS: Of the 101 original patients, 93 were eligible for follow-up at a mean of 7.5 years (range, 2.1 to 10). Clinical outcomes were compared with Harris Hip, 12-Item Short Form Health Survey, and Hip Disability and Osteoarthritis Outcomes Scores (HOOS) scores and subscores, complications, reoperations, and revisions. RESULTS: Harris Hip scores were similar (95.3 ± 6.0 versus 93.5 ± 10.3 for DAA and MPA, respectively, P = .79). The 12-Item Short Form Health Survey physical and mental scores were similar (46.2 ± 9.3 versus 46.2 ± 10.6, P = .79, and 52.3 ± 7.1 versus 55.2 ± 4.5, P = .07 in the DAA and MPA groups, respectively). The HOOS scores were similar (97.4 ± 7.9 versus 96.3 ± 6.7 for DAA and MPA, respectively, P = .07). The HOOS quality of life subscores were 96.9 ± 10.8 versus 92.3 ± 16.0 for DAA and MPA, respectively (P = .046). No clinical outcome met the minimally clinically important difference. There were 4 surgical complications in the DAA group (1 femoral loosening requiring revision, 1 dislocation treated closed, and 2 wound dehiscences requiring debridement), and 6 surgical complications in the MPA group (3 dislocations, 2 treated closed, and 1 revised to dual mobility; 2 intraoperative fractures treated with a cable; and 1 wound dehiscence treated nonoperatively). CONCLUSIONS: At a mean of 7.5 years, this randomized clinical trial demonstrated no clinically meaningful differences in outcomes, complications, reoperations, or revisions between DAA and MPA total hip arthroplasty. LEVEL OF EVIDENCE: IV.
引用
- Roberts HJ, Hadley ML, Mallinger BD, et al. A Randomized Clinical Trial of Direct Anterior Versus Mini-Posterior Total Hip Arthroplasty: Small, Early Functional Differences Did Not Lead to Meaningful Clinical Differences at 7.5 Years. J Arthroplasty. 2024. PMID: 38735544. doi:10.1016/j.arth.2024.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。